This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Chimera Investment Enters Oversold Territory
by Zacks Equity Research
Chimera Investment has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock.
Top Ranked Income Stocks to Buy for April 3rd
by Zacks Equity Research
Here are four stocks with buy rank and strong income characteristics for investors to consider today, April 3rd
The Zacks Analyst Blog Highlights: Enviva, MGM, Chimera, DCP and Teekay
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Enviva, MGM, Chimera, DCP and Teekay
Do Options Traders Know Something About Chimera (CIM) Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to Chimera (CIM) stock based on the movements in the options market lately.
5 High-Yield Stocks to Defy Coronavirus-Led Crisis in April
by Zacks Equity Research
With the steep rise in coronavirus cases, we have shortlisted five high-yield stocks that can offer sizable returns amid this crisis
AGNC Investment (AGNC) Issues Update Amid Coronavirus Mayhem
by Zacks Equity Research
AGNC Investment's (AGNC) leverage and liquidity levels benefit from its concerted efforts and the Fed's aggressive actions to support the mortgage market.
Chimera (CIM): Strong Industry, Solid Earnings Estimate Revisions
by Zacks Equity Research
Chimera (CIM) has seen solid earnings estimate revision activity over the past two months, and belongs to a strong industry as well.
4 REIT Stocks to Buy Amid Coronavirus-Induced Market Maelstrom
by Shuvra Shankar Dey
REITs are considered bond proxies for their high high-dividend paying nature. Their dependence on debt is a positive amid lower borrowing costs due to back-to-back rate cuts.
Top Ranked Income Stocks to Buy for March 20th
by Zacks Equity Research
Here are four stocks with buy rank and strong income characteristics for investors to consider today, March 20th
Chimera Investment Sees Hammer Chart Pattern: Time to Buy?
by Zacks Equity Research
Chimera Investment has been struggling lately, but the selling pressure may be coming to an end soon.
4 Dividend Stocks to Buy Amid Coronavirus-Led Recession Fear
by Shuvra Shankar Dey
Dividend-paying stocks with healthy yields are safe bets now as they have strong prospects, and provide a cushion against large swings in the market.
What Makes Chimera (CIM) a New Strong Buy Stock
by Zacks Equity Research
Chimera (CIM) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Top Ranked Income Stocks to Buy for March 11th
by Zacks Equity Research
Here are four stocks with buy rank and strong income characteristics for investors to consider today, March 11th
Top Ranked Income Stocks to Buy for March 10th
by Zacks Equity Research
Here are four stocks with buy rank and strong income characteristics for investors to consider today, March 10th
Top Rate-Sensitive, Coronavirus-Resistant Picks for You
by Shuvra Shankar Dey
The emergency rate cut, undoubtedly, brings REITs and Utilities at the forefront.
Earnings Preview: Chimera Investment (CIM) Q4 Earnings Expected to Decline
by Zacks Equity Research
Chimera (CIM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
AGNC Investment's (AGNC) Q4 Earnings Beat Estimates, NII Up
by Zacks Equity Research
AGNC Investment's (AGNC) Q4 earnings reflect growth in comprehensive income per common share and net interest income.
Chimera Investment (CIM) Lags Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Chimera (CIM) delivered earnings and revenue surprises of -1.96% and -0.64%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Chimera Investment (CIM) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Chimera (CIM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
AGNC Investment (AGNC) Q2 Earnings Lag Estimates, NII Slips
by Zacks Equity Research
AGNC Investment's (AGNC) Q2 earnings indicate a decline in net interest income. Further, the company's tangible net book value per share witnesses a year-over-year decline.
Analysts Estimate Chimera Investment (CIM) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Chimera (CIM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Chimera (CIM) to Post Q1 Earnings: What's in the Offing?
by Zacks Equity Research
Given the recovery in the agency MBS sector, Chimera Investment (CIM) will likely reap benefits of higher exposure to this investment vehicle in Q1.
AGNC Investment's (AGNC) Q1 Earnings Miss, Dividend Cut
by Zacks Equity Research
AGNC Investment (AGNC) first-quarter 2019 earnings indicate a decline in net interest income. Further, the company suggests a decline in its monthly dividends.
Analysts Estimate Chimera Investment (CIM) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Chimera (CIM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Should You Hold AGNC Investment Stock in Your Portfolio Now?
by Zacks Equity Research
AGNC Investment (AGNC) is making efforts to reposition its portfolio in order to hedge interest rate risks. However, volatile market and choppiness in global economic environment remain concerns.